SUBSCRIBE
SUBSCRIBE
News   Drug Development

Ariad Pharmaceuticals, Inc. (JOBS) Says Independent Experts Positive on Cancer Drug

September 14, 2009 | 
1 min read
Bookmark and Share

Reuters -- Ariad Pharmaceuticals Inc said an independent committee of experts recommended that a late-stage trial of the company's experimental cancer treatment may continue, sending its shares up 12 percent.
Clinical research Phase III
MORE ON THIS TOPIC
Pictured: Bristol Myers Squibb office in California
Neuropsychiatric disorders
‘Strike 2?’ BMS Stumbles Again as Cobenfy Disappoints in Schizophrenia
April 23, 2025
 · 
2 min read
 · 
Tristan Manalac
Gilead's headquarters in Silicon Valley
Breast cancer
Gilead’s Trodelvy, With Keytruda, Slows Disease Progression in Triple-Negative Breast Cancer
April 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Breast Cancer awareness month card illustration. Pink ribbon and hand fist up power in retro collage craft style. Design concept for disease prevention or october support campaign.
Breast cancer
AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data
April 22, 2025
 · 
2 min read
 · 
Tristan Manalac
Rug pull crypto, scam coin, trading problem, investment risk in unstable and uncertainty stock market concepts. Unknown people pull carpet and make businesspeople who standing on money falling down.
FDA
FDA’s User Fee Negotiation Teams Gutted by Layoffs: Reuters
April 18, 2025
 · 
2 min read
 · 
Tristan Manalac